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Regulation of gene expression in all living cells rests upon
selective interactions of regulatory proteins with specific
nucleic acid sequences. In addition bacteria use short RNA
transcripts to control the replication of plasmid DNA or
translation of some mRNAs. Synthetic oligodeoxynucleotides
have been used to block mRNA translation selectively (for
review see Toulm6 & Helene, 1988). The utilisation of
oligonucleotides in vivo faces two main problems: (1) they
penetrate rather poorly across cell membranes and (2) they
are degraded by nucleases. The second problem has been
solved by synthesising nuclease-resistant analogues of oligo-
deoxynucleotides. This can be achieved by replacing the
phosphate group by a methylphosphonate or a phosphoro-
thioate or by changing the anomeric configuration of the
nucleoside units from /P to a.
In this review I will briefly describe the approach we have
been following to design new oligodeoxynucleotide
derivatives that can be used to control gene expression at
different levels. The binding of an oligonucleotide to its
complementary sequence can be strongly enhanced by
attaching an intercalating agent to one (or both) end(s) of
the oligonucleotide. Besides increasing the binding strength
the intercalating agent improves cellular uptake of the
oligonucleotide and protects it against exonucleases. The
oligonucleotide can be further substituted by a reactive
group that can be activated chemically or photochemically to
induce irreversible reactions in the target nucleic acid. In
addition to binding mRNAs oligonucleotides can be
designed to bind to duplex DNA, which opens new ways to
control gene expression at the transcriptional level.
Design of oligonucleotides covalently linked to intercalating
agents as specific gene control elements
The first question that is raised concerns the specificity of
biological effects of synthetic oligonucleotides: what should
be the minimum length that the oligonucleotide should have
in order to recognise a single target in either a genome or a
messenger RNA population? No bacterial or eukaryotic
genome has been totally sequenced yet. Assuming a
statistical distribution of nucleotides it is possible to calculate
that, on average, an oligonucleotide 12 nucleotides in length
should be sufficient to recognise a single sequence in the E.
coli genome. In human cells where the (A+T)/(G+C) ratio is
around 0.6 the minimum length should range from 15 (only
Gs and Cs in the oligonucleotide) to 19 (only As and Ts)
when a genomic sequence is the target, and from 11 to 15 if
the target is a mRNA (assuming that about 0.5% of the
genome is transcribed into mRNA in a given cell type). The
calculated length depends on the actual sequence, especially
for (G+C)-rich oligonucleotides, because one dinucleotide
sequence, CpG, is under-represented in eukaryotic genomes
as compared to a statistical distribution.
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The conclusion that these calculations suggests is that
short oligonucleotides are sufficient to attain a high
selectivity of biological effects. There are many advantages
to using short oligomers including the absence of secondary
structures (hairpins), easier synthesis and purification
(especially when chemical modifications are introduced) and
easier cell uptake. In order to keep the advantages of using
short oligonucleotides but to improve the binding to a
complementary sequence we have covalently attached inter-
calating agents to one (or both) end(s)-(Asseline et al., 1983,
1984). The complex that is formed involves not only base
pairing and base pair stacking but also intercalation between
terminal base pairs of the mini-duplex structure. The
additional binding energy due to intercalation strongly
stabilizes the complex without altering the oligonucleotide
specificity.
In addition to stabilising the complex formed by an
oligodeoxynucleotide with its complementary sequence the
intercalating agent improves the penetration across cell
membranes and protects the oligodeoxynucleotide against
exonucleases.
Biological effects of oligonucleotides covalently linked to
intercalating agents
Inhibition of mRNA translation
Oligonucleotide-intercalator conjugates were used to inhibit
both prokaryotic (Toulm6 et al., 1986) and eukaryotic
(Cazenave et al., 1987a) mRNA translation in cell-free
extracts. Microinjection into Xenopus laevis oocytes showed
that translation inhibition occurred in an intact living cell
(Cazenave et al., 1987a). The mechanism of the inhibitory
effect was analysed further. It turned out that a cellular
component played an essential role. A ribonuclease, known
as RNase H, recognised the mRNA-oligodeoxynucleotide
hybrid and cleaved the RNA part. This effect was specific
for oligodeoxynucleotides since RNase H recognises RNA-
DNA and not RNA-RNA hybrids. Cleavage of the mRNA
induced an irreversible block of mRNA translation.
Anti-viral effects
Influenza virus The eight RNAs that constitute the genome
of influenza virus have a common sequence at their 3'-end.
This sequence was chosen as a target for oligonucleotide-
intercalator conjugates. The cytopathic effect of type A
influenza virus on MDCK cells in culture was blocked by a
heptanucleotide covalently linked to an acridine derivative.
In vitro studies showed that the RNA transcriptase of the
virus was inhibited. The effect was sequence-specific. A type
B influenza virus which differs from a type A virus by the
sequence of the 3'-termini was not inhibited by the oligo-
nucleotide directed against the type A sequence (Zerial et al.,
1987).
Oncogenic virus SV40 An oligonucleotide-intercalator
conjugate complementary to a sequence present in the origin
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of replication of the viral SV40 DNA inhibited the cyto-
pathic effect of the virus on CV1 cells in culture. DNA
replication was blocked in a sequence-specific manner.
Binding of the oligonucleotide to the transiently open origin
of replication or triple helix formation (see below) might
account for the observed effect.
Anti-parasitic effects
The mRNAs of trypanosomes, the parasites responsible for
sleeping sickness, have a common sequence of 39 nucleotides
at their 5'-end. Translation of all mRNA species could be
inhibited in vitro by a nonanucleotide-intercalator conjugate
targeted to part of this common sequence. Protein synthesis
was completely abolished. The same oligonucleotide killled
procyclic forms of the parasite in a culture medium. The
observed effect was sequence-specific and was not observed
when the oligonucleotide was not covalently linked to the
acridine derivative (Verspieren et al., 1987). Other parasites
such as leishmania also have a common sequence at the 5'-
end of their mRNA. Protein synthesis can be selectively
inhibited by oligonucleotide-intercalator conjugates.
Inhibition of oncogenes
Oncogenes are cellular genes that are activated in tumour
cells as a result of translocation, gene amplification or
mutations. We have designed short oligonucleotide-
intercalator conjugates targeted to the human c-myc and Ha-
ras mRNAs. In a cell-free system the translation of these
mRNAs is efficiently inhibited. The inhibition depends on
the presence of RNase H which hydrolyses the mRNAs
when hybridised to the oligodeoxynucleotide. In cells in
culture several laboratories have reported that myc gene
expression could be inhibited by an unsubstituted oligo-
deoxynucleotide, 15 in length, targeted downstream of the
AUG initiation codon (Heikkila et al., 1987; Holt et al.,
1988; Harel-Bellan et al., 1988; Wickstr6m et al., 1988).
Using the T24 cell line derived from a bladder carcinoma in
which the Ha-ras gene is activated by a mutation in the 12th
codon we were able to show that an oligonucleotide-acridine
conjugate targeted to a sequence overlapping the mutation
inhibited cell division and changed the cell morphology (T.
Saison-Behmoaras et al., to be published).
Irreversible reactions induced in target nucleic acids
In all examples briefly described above the
oligodeoxynucleotide-intercalator conjugate binds reversibly
to its target mRNA or viral RNA. In several cases it has
been demonstrated that the mRNA is irreversibly inactivated
as a result of its being cleaved by RNase H, which
recognises the mRNA-oligodeoxynucleotide hybrid
(Cazenave et al., 1987a). However, the oligodeoxynucleotide
is itself sensitive to DNases. Therefore several modifications
were introduced into the oligonucleotide in order to make it
resistant to nucleases. The phosphate group can be replaced
by a methylphosphonate or by a phosphorothioate (Marcus-
Sekura et al., 1987). The natural fl-anomers of the nucelotide
units can be replaced by their synthetic a-anomers (Morvan
et al., 1987; Thuong et al., 1987). Oligo-(o)-deoxynucleotides
can be covalently linked to intercalating agents (for review
see He1ne & Thuong, 1988). They bind in a parallel
orientation with respect to their complementary sequence.
Oligophosphorothiotes form RNase H-sensitive hybrids with
RNAs (Stein et al., 1988). However, oligomethyl-
phosphonates (unpublished results) and oligo-(ae)-
deoxynucleotides (Gagnor et al., 1987) form hybrids with
RNAs which are not cleaved by RNase H. These modified
oligonucleotides are resistant to DNases and therefore their
lifetime in living cells is considerably increased (Cazenave et
al., 1987b). They are not cytotoxic at high concentrations
(up to 100UM) whereas oligophosphorothioates exhibit
toxicity in the micromolar range. In order to take advantage
of their resistance to DNases and of their lack of cyto-
toxicity we have modified oligo-(a)-deoxynucleotides so as to
make them able to induce irreversible reactions in their
target mRNA. This has been achieved in two different ways.
Attachment of a nucleic acid-cleaving reagent to one end of
the oligonucleotide
The other end can be substituted by an intercalating agent.
Metal complexes such as EDTA-Fe (Chu & Orgel, 1985;
Dreyer & Dervan, 1985; Boidot-Forget et al., 1986, 1988);
phenanthroline-Cu (Chen & Sigman, 1986; Frangois et al.,
1988a; Sun et al., 1988) and porphyrin-Fe (Le Doan et al.,
1986, 1987a) can be used to generate OH radicals in the
presence of oxygen and a reducing agent. These radicals
induce cleavage reactions targeted to the sequence
complementary of the oligonucleotide carrier. RNA can be
cleaved as well as DNA (Chen & Sigman, 1988 and
unpublished results).
Covalent linkage ofa photoactive group to the oligonucleotide
An intercalating agent such as proflavine can be used as a
photosensitiser (Praseuth et al., 1988b). All the photoactive
groups described until now lead to photocrosslinking of the
oligonucleotide to its target sequence. These groups include
azidophenacyl (Praseuth et al., 1988a), azidoproflavine
(Le Doan et al., 1987b), proflavine (Praseuth et al., 1988b),
porphyrins (in preparation) and furocoumarins (Lee et al.,
1988; Gamper et al., 1987). In addition, photo-oxidations of
bases are induced by porphyrins and proflavine (Praseuth et
al., 1988a).
Oligomethylphosphonates covalently linked to a
furocoumarin have been recently shown to be efficient
inhibitors of mRNA translation following irradiation (Kean
et al., 1988). Other modifications, such as attachment of
alkylating agents (Knorre & Vlassov, 1985), have also been
proposed to induce irreversible reactions in complementary
sequences.
The DNA double helix as a target for oligonucleotides
The major groove of the DNA double helix can be
recognised at homopurine homopyrimidine sequences by
homopyrimide oligonucleotides. Pairs of hydrogen bonds are
formed by thymine with an A-T Watson-Crick base pair and
by protonated cytosine with a G-C base pair. A triple helix
is locally formed (Le Doan et al., 1987b; Moser & Dervan,
1987; Praseuth et al., 1988a; Franqois et al., 1988b). It is also
possible to form a triple helix with a homopurine oligo-
nucleotide that can recognise the purine-containing strand at
a homopurine-homopyrimidine sequence (Cooney et al.,
1988). In all cases the oligonucleotide is bound in a parallel
orientation with respect to the purine-containing strand of
the double helix. Irreversible reactions can be induced when
the oligonucleotide carries a reactive group such as a photo-
crossliner (Le Doan et al., 1987b; Praseuth et al., 1988a) or a
DNA-cleaving reagent such as EDTA-Fe (Moser & Dervan,
1987) or phenanthroline-Cu (Francois et al., 1988c). In the
last case double-strand cleavage can be achieved thereby
leading to the development of sequence-specific (restriction-
like) endonucleases.
Triple helix formation opens new possibilities to control
gene expression at the transcriptional level. It has been
recently reported that myc gene transcription could be
inhibited in vitro by a purine-rich oligonucleotide recognising
a sequence upstream of the transcription initiation site
(Cooney et al., 1988). It should also be kept in mind that the
double helix is transiently open during transcription and that
inhibition can be achieved by oligonucleotides
complementary to one strand in the open region (H6elene et
al., 1985). Nuclease-resistant oligo-(a)-deoxynucleotides also
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(Le Doan et al., 1987b; Praseuth et al., 1988a). Therefore
they could be used in vivo to control gene expression at the
transcriptional level.
Conclusions
Oligodeoxynucleotides covalently linked to intercalating
agents offer several advantages as compared to unsubstituted
oligonucleotides: (1) their complexes with a complementary
sequence are stabilised by the additional binding energy
provided by intercalation; (2) their penetration across cell
membranes is improved; (3) they are protected against
degradation by exonucleases - 3'-substitution protects
against 3'-exonucleases which are very active in biological
fluids. These substituted oligodeoxynucleotides induce a
cleavage of their target mRNA by endogenous RNase H,
thereby inhibiting mRNA translation irreversibly. Oligo-
deoxynucleotides can be made resistant to DNases by
modifying the phosphodiester backbone or changing the
anomeric configuration of the nucleosides. Some of these
modifications abolish the RNase H-induced degradation of
target mRNAs. Irreversible reactions can be induced in the
target sequence by attaching a nucleic acid-cleaving reagent,
an alkylating agent or photoactive reagent to the oligo-
nucleotide. The DNA double helix is also a target for
oligodeoxynucleotide carrying reactive groups. All these
recent developments open new possibilities to control gene
expression selectively at different levels and provide a
rational basis for the conception of highly specific
therapeutic agents.
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